AMRN News and Press, Amarin Corporation plc From 05/23/23

2023-05-23 09:50:41 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks have gotten caught up in the broader technology sector sell-off. The benchmark iShares Biotechnology ETF (NYSEARCA: IBB ) has fallen from a peak of ...

— New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression — --Data Further Advances Understanding of VASCEPA/VAZKEPA Potential Mechanism of Action-- DUBLIN, Ireland and BRIDGEWATER, N.J., May 12, 20...

2023-05-08 18:00:12 ET Alkermes' ( NASDAQ: ALKS ) board said that they declined to endorse any of Sarissa Capital Management's three nominees after conducting interviews. The board said it is hoping to find a resolution that would avoid a contested election and proxy battle. ...

2023-05-03 14:00:53 ET Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q1 2023 Earnings Call May 03, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin Plc (AMRN) Q1 2023 Earnings Call Transcript

2023-05-03 10:03:02 ET Amarin Corporation plc (AMRN) Q1 2023 Earnings Conference Call May 03, 2023, 08:00 AM ET Company Participants Lisa DeFrancesco - Senior Vice President, Corporate Affairs and Investor Relations Aaron Berg - Interim President & Chief Executiv...

2023-05-03 09:24:24 ET Amarin Corporation ( NASDAQ: AMRN ) reported better than expected financials for Q1 2023 on Wednesday, even as its topline contracted ~9% YoY amid generic competition to its fish oil-derived heart disease therapy Vazkepa. The Ireland-based biotech posted $...

2023-05-03 07:02:25 ET Amarin press release ( NASDAQ: AMRN ): Q1 Non-GAAP EPS of -$0.02 misses by $0.01 . Revenue of $85.7M (-9.4% Y/Y) beats by $4.47M . For further details see: Amarin Non-GAAP EPS of -$0.02 misses by $0.01, revenue of $85.7M beats by $4...

-- Stable Revenue and Cash Position Due to Performance of U.S. Business and Savings from Operational Initiatives -- -- Early Progress in Launch of VAZKEPA ® (icosapent ethyl) in England & Wales; Pricing & Reimbursement Discussions in Key European Markets Ongoing -- ...

DUBLIN, Ireland and BRIDGEWATER, N.J., April 19, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that it will host a conference call with Aaron Berg, Interim President & CEO, and members of Amarin’s senior management team to discuss the Company’s f...

2023-04-17 07:11:02 ET Amarin ( NASDAQ: AMRN ) announced on Monday the appointment of Aaron Berg as interim president and CEO, effective immediately. Berg, who has more than 25 years of biopharmaceutical industry experience, currently serves as Amarin's executive vice pres...